BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image
Active

Symbiotec Pharmalab Limited

Symbiotec Pharmalab Limited IPO Details

Listing Date

-

Bid Price

₹0 - ₹0

Lot Size

0 Shares

Minimum Investment

Issue Size

₹0 Crores

Schedule

    Here are the important dates you need to know in order to participate in this IPO

tick

Bidding starts

-

tick

Bidding ends

-

tick

Allotment of shares

-

tick

Initiation of refund

-

tick

Credit of shares to Demat account

-

tick

Listing date

-

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 0% 0%
Public Group 100% 100%

Symbiotec Pharmalab Limited IPO Reservation

QIB Shares Offered 0 (0%)
NII (HNI) Shares Offered 0 (0%)
Retail Shares Offered 0 (0%)
Anchor Investor Shares Offered 0 (0%)
Total Shares Offered 0
Total Shares With Anchor Investor 0

Symbiotec Pharmalab Limited IPO Lot Size

Application Lots Shares Amount
Retail (Min) [-] [-] ₹[-]
Retail (Max) [-] [-] ₹[-]
S HNI (Min) [-] [-] ₹[-]
S HNI (Max) [-] [-] ₹[-]
B HNI (MIN) [-] [-] ₹[-]

Symbiotec Pharmalab Limited IPO registrar

MUFG Intime India Pvt Ltd
Phone Number +91 810 811 4949
Email Id symbiotecpharmalab.ipo@in.mpms.mufg.com
Website https://in.mpms.mufg.com

Symbiotec Pharmalab Limited IPO Lead Manager

1. JM Financial Limited

2. Avendus Capital Private Limited

3. Motilal Oswal Investment Advisors Limited

4. Nomura Financial Advisory & Securities (I) Pvt Ltd

Symbiotec Pharmalab Limited Financial Information

March 31, 2024 March 31, 2023 March 31,
Net Worth ₹715.05 cr ₹621.53 cr ₹ cr
Reserves and Surplus ₹704.11 cr ₹610.6 cr ₹ cr
Total Borrowing ₹247.21 cr ₹217.88 cr ₹ cr

Symbiotec Pharmalab Limited IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed
Qualified Institutional Buyers (QIBs) 0 0 0
Non Institutional Investors (NIIs) 0 0 0
NII(Bid amount of more than Ten Lakh Rupees) 0 0 0
NII(Bid amount of more than 2 Lakh < 10 Rupees) 0 0 0
Retail Individual Investors (RIIs) 0 0 0
Total 0 0 0

Strength of Symbiotec Pharmalab Limited

Risks Involved

  • We derive almost all of our revenue from the sale of APIs, which collectively constituted 100.00%, 99.10%, 100.00% and 100.00% of our revenue from operations in the three months period ended June 30, 2025 and in Fiscals 2025, 2024 and 2023, respectively. Further, our top five APIs constituted 65.11%, 63.16%, 60.37% and 66.36% of our revenue from operations in the three months period ended June 30, 2025 and in Fiscals 2025, 2024 and 2023, respectively. Any reduction in demand for APIs, and our top products in particular, could have an adverse effect on our business, results of operations, financial condition and cash flows.
  • Our manufacturing facilities are subject to periodic inspections and audits by regulatory authorities and our customers. Any manufacturing or quality control failures may subject us to regulatory action, damage our reputation and have an adverse effect on our business, results of operations, financial condition and cash flows.
  • We export our products to various countries and our revenue from external customers outside India as per Ind AS 108 - "Operating Segments" represented 66.67%, 55.19%, 59.97%, and 52.76% of our revenue from operations in the three months period ended June 30, 2025 and in Fiscals 2025, 2024 and 2023, respectively. Our inability to handle risks associated with our export sales could adversely affect our sales to customers in foreign countries, our results of operations, financial condition and cash flows.
  • In the three months period ended June 30, 2025 and in Fiscals 2025, 2024 and 2023, revenue from the United States represented 11.61%, 4.02%, 8.97%, and 4.39% of our revenue from operations. The imposition of tariffs or other anti-outsourcing legislation by the United States could adversely affect our results of operations, financial condition and cash flows.
  • We derive a substantial portion of our revenue from certain key customers. Revenue generated from our top ten customers accounted for 64.01%, 55.90%, 61.65% and 60.65% of our revenue from sale of product except one-off item in the three months period ended June 30, 2025 and in Fiscals 2025, 2024 and 2023, respectively. Loss of our relationship with any of these customers or delays or reductions in their orders could have an adverse effect on our business, results of operations, financial condition and cash flows.
  • Our manufacturing facilities are located in the state of Madhya Pradesh in India. Any adverse developments affecting Madhya Pradesh or its surrounding regions could adversely affect our business, results of operations, financial condition and cash flows. A slowdown, interruption or shutdown in our manufacturing operations could have an adverse effect on our business, results of operations, financial condition and cash flows.
  • We depend on certain suppliers for raw materials for our operations. Purchases from our top ten suppliers accounted for 17.90%, 18.41%, 50.33% and 34.95% of our total expenses in the three months period ended June 30, 2025 and in Fiscals 2025, 2024 and 2023, respectively. Any loss of such suppliers or nonperformance of their obligations could adversely affect our business, results of operations, financial condition and cash flows.
  • We procure a portion of our raw material requirements from different countries, including China and the United States. Any adverse developments in these countries, or the laws governing our imports from these countries, could disrupt our raw material supply and adversely affect our results of operations, financial condition and cash flows.
  • Our success depends on our ability to develop and commercialise new products in a timely manner. If our research and development efforts do not succeed, or the products we commercialise do not perform as expected, the introduction of new products may be hindered, which could adversely affect our business, results of operations, financial condition and cash flows.
  • Our operations involve activities and materials which are hazardous in nature and could result in a suspension of operations, injury to our personnel, emission of pollutants or the imposition of civil or criminal liabilities, which could adversely affect our business, results of operations, financial condition and cash flows.
stock

Invest in IPOs with ease

Sign-in to invest with your demat account, or set up a new demat account for free

Explore Other IPOs

  • Current IPOs
  • Upcoming IPOs
  • Closed IPOs
  • IPO Performance
  • All
  • MainBoard
  • SME
DACHEPALLI PUBLISHERS LIMITED IPO
Closing Tomorrow
Bidding Period
22nd Dec 2025 - 12th Dec 2025
Price Range
₹100.0 - 102.0
IPO Size
₹40,39,00,000
EPW INDIA LIMITED IPO
Closing Tomorrow
Bidding Period
22nd Dec 2025 - 12th Dec 2025
Price Range
₹95.0 - 97.0
IPO Size
₹31,81,00,000
GUJARAT KIDNEY AND SUPER SPECIALITY LIMITED IPO
Closing Tomorrow
Bidding Period
22nd Dec 2025 - 12th Dec 2025
Price Range
₹108.0 - 114.0
IPO Size
₹2,50,80,00,000
SHYAM DHANI INDUSTRIES LIMITED IPO
Closing Tomorrow
Bidding Period
22nd Dec 2025 - 12th Dec 2025
Price Range
₹65.0 - 70.0
IPO Size
₹38,49,00,000
SUNDREX OIL COMPANY LIMITED IPO
Closing Tomorrow
Bidding Period
22nd Dec 2025 - 12th Dec 2025
Price Range
₹81.0 - 86.0
IPO Size
₹32,25,00,000
NANTA TECH LIMITED IPO
Bidding Period
23rd Dec 2025 - 12th Dec 2025
Price Range
₹209.0 - 220.0
IPO Size
₹31,81,00,000
DHARA RAIL PROJECTS LIMITED IPO
Bidding Period
23rd Dec 2025 - 12th Dec 2025
Price Range
₹120.0 - 126.0
IPO Size
₹50,20,00,000
ADMACH SYSTEMS LIMITED IPO
Bidding Period
23rd Dec 2025 - 12th Dec 2025
Price Range
₹227.0 - 239.0
IPO Size
₹42,60,00,000
APOLLO TECHNO INDUSTRIES LIMITED IPO
Bidding Period
23rd Dec 2025 - 12th Dec 2025
Price Range
₹123.0 - 130.0
IPO Size
₹47,96,00,000
BAIKAKAJI POLYMERS LIMITED IPO
Bidding Period
23rd Dec 2025 - 12th Dec 2025
Price Range
₹177.0 - 186.0
IPO Size
₹1,05,17,00,000
E TO E TRANSPORTATION INFRASTRUCTURE LIMITED IPO
Bidding Period
26th Dec 2025 - 12th Dec 2025
Price Range
₹164.0 - 174.0
IPO Size
₹84,22,00,000
  • All
  • MainBoard
  • SME
Aarvee Engineering Consultants Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aastha Spintex Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AceVector Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanced SysTek Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advit Jewels Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aggcon Equipments International Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Agilus Diagnostics Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Airox Technologies Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ajay Poly Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alcobrew Distilleries India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allchem Lifescience Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allied Engineering Works Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alpine Texworld Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Amagi Media Labs Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Amir Chand Jagadish Kumar Exports Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Annu Projects Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AOne Steels India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
APPL Containers Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ardee Engineering Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ardee Industries Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
NO ACTIVE IPO HERE
  • All
  • MainBoard
  • SME
PHYTOCHEM REMEDIES INDIA LIMITED IPO
Bidding Period
18th Dec 2025 - 12th Dec 2025
Price Range
₹98.0 - 98.0
IPO Size
₹38,22,00,000
MARC TECHNOCRATS LIMITED IPO
Bidding Period
17th Dec 2025 - 12th Dec 2025
Price Range
₹88.0 - 93.0
IPO Size
₹42,59,00,000
KSH INTERNATIONAL LIMITED IPO
Bidding Period
16th Dec 2025 - 12th Dec 2025
Price Range
₹365.0 - 384.0
IPO Size
₹7,10,00,00,000
NEPTUNE LOGITEK LIMITED IPO
Bidding Period
15th Dec 2025 - 12th Dec 2025
Price Range
₹126.0 - 126.0
IPO Size
₹46,62,00,000
ASHWINI CONTAINER MOVERS LIMITED IPO
Bidding Period
12th Dec 2025 - 12th Dec 2025
Price Range
₹135.0 - 142.0
IPO Size
₹71,00,00,000
EXIM ROUTES LIMITED IPO
Bidding Period
12th Dec 2025 - 12th Dec 2025
Price Range
₹83.0 - 88.0
IPO Size
₹43,73,00,000
ICICI PRUDENTIAL ASSET MANAGEMENT CO LIMITED IPO
Bidding Period
12th Dec 2025 - 12th Dec 2025
Price Range
₹2061.0 - 2165.0
IPO Size
₹1,06,02,65,00,000
STANBIK AGRO LIMITED IPO
Bidding Period
12th Dec 2025 - 12th Dec 2025
Price Range
₹30.0 - 30.0
IPO Size
₹12,28,00,000
HRS ALUGLAZE LIMITED IPO
Bidding Period
11th Dec 2025 - 12th Dec 2025
Price Range
₹94.0 - 96.0
IPO Size
₹50,92,00,000
PAJSON AGRO INDIA LIMITED IPO
Bidding Period
11th Dec 2025 - 12th Dec 2025
Price Range
₹112.0 - 118.0
IPO Size
₹74,45,00,000
PARK MEDI WORLD LIMITED IPO
Bidding Period
10th Dec 2025 - 12th Dec 2025
Price Range
₹154.0 - 162.0
IPO Size
₹9,20,00,00,000
SHIPWAVES ONLINE LIMITED IPO
Bidding Period
10th Dec 2025 - 12th Dec 2025
Price Range
₹12.0 - 12.0
IPO Size
₹56,35,00,000
NEPHROCARE HEALTH SERVICES LIMITED IPO
Bidding Period
10th Dec 2025 - 12th Dec 2025
Price Range
₹438.0 - 460.0
IPO Size
₹8,71,05,00,000
UNISEM AGRITECH LIMITED IPO
Bidding Period
10th Dec 2025 - 12th Dec 2025
Price Range
₹63.0 - 65.0
IPO Size
₹21,45,00,000
WAKEFIT INNOVATIONS LIMITED IPO
Bidding Period
8th Dec 2025 - 12th Dec 2025
Price Range
₹185.0 - 195.0
IPO Size
₹12,88,89,00,000
K V TOYS INDIA LIMITED IPO
Bidding Period
8th Dec 2025 - 12th Dec 2025
Price Range
₹227.0 - 239.0
IPO Size
₹40,15,00,000
RIDDHI DISPLAY EQUIPMENTS LIMITED IPO
Bidding Period
8th Dec 2025 - 12th Dec 2025
Price Range
₹95.0 - 100.0
IPO Size
₹24,68,00,000
PRODOCS SOLUTIONS LIMITED IPO
Bidding Period
8th Dec 2025 - 12th Dec 2025
Price Range
₹131.0 - 138.0
IPO Size
₹27,60,00,000
CORONA REMEDIES LIMITED IPO
Bidding Period
8th Dec 2025 - 12th Dec 2025
Price Range
₹1008.0 - 1062.0
IPO Size
₹6,55,37,00,000
ENCOMPASS DESIGN INDIA LIMITED IPO
Bidding Period
5th Dec 2025 - 12th Dec 2025
Price Range
₹101.0 - 107.0
IPO Size
₹40,21,00,000
  • All
  • MainBoard
  • SME
NEPTUNE LOGITEK LIMITED IPO
Issue Prize
126.00
Listing Day Close
95.80(-23.81%)
ASHWINI CONTAINER MOVERS LIMITED IPO
Issue Prize
142.00
Listing Day Close
140.10(-1.41%)
EXIM ROUTES LIMITED IPO
Issue Prize
88.00
Listing Day Close
115.50(31.82%)
ICICI PRUDENTIAL ASSET MANAGEMENT CO LIMITED IPO
Issue Prize
2165.00
Listing Day Close
2586.70(19.49%)
STANBIK AGRO LIMITED IPO
Issue Prize
30.00
Listing Day Close
33.33(10.00%)
HRS ALUGLAZE LIMITED IPO
Issue Prize
96.00
Listing Day Close
132.30(37.50%)
PAJSON AGRO INDIA LIMITED IPO
Issue Prize
118.00
Listing Day Close
130.20(10.17%)
PARK MEDI WORLD LIMITED IPO
Issue Prize
162.00
Listing Day Close
148.15(-8.64%)
SHIPWAVES ONLINE LIMITED IPO
Issue Prize
12.00
Listing Day Close
11.40(-8.33%)
NEPHROCARE HEALTH SERVICES LIMITED IPO
Issue Prize
460.00
Listing Day Close
471.60(2.61%)
UNISEM AGRITECH LIMITED IPO
Issue Prize
65.00
Listing Day Close
61.75(-4.62%)
WAKEFIT INNOVATIONS LIMITED IPO
Issue Prize
195.00
Listing Day Close
192.30(-1.54%)
K V TOYS INDIA LIMITED IPO
Issue Prize
239.00
Listing Day Close
336.00(40.59%)
RIDDHI DISPLAY EQUIPMENTS LIMITED IPO
Issue Prize
100.00
Listing Day Close
76.00(-24.00%)
PRODOCS SOLUTIONS LIMITED IPO
Issue Prize
138.00
Listing Day Close
151.20(9.42%)
CORONA REMEDIES LIMITED IPO
Issue Prize
1062.00
Listing Day Close
1437.20(35.31%)
ENCOMPASS DESIGN INDIA LIMITED IPO
Issue Prize
107.00
Listing Day Close
193.15(80.37%)
FLYWINGS SIMULATOR TRAINING CENTRE LIMITED IPO
Issue Prize
191.00
Listing Day Close
204.75(7.33%)
METHODHUB SOFTWARE LIMITED IPO
Issue Prize
194.00
Listing Day Close
162.90(-15.98%)
LUXURY TIME LIMITED IPO
Issue Prize
82.00
Listing Day Close
163.59(100.00%)

Frequently Asked Questions

What is Symbiotec Pharmalab Limited IPO?

Answer Field

Symbiotec Pharmalab Limited IPO is a IPO of [-] equity shares of a face value of ₹[-] aggregating up to ₹[-] Crores. The issue is priced at ₹[-] to ₹[-] per share. The minimum order quantity is [-] Shares. The IPO opens on [-], and closes on [-]. MUFG Intime India Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on .

When Symbiotec Pharmalab Limited IPO will open?

Answer Field

The Symbiotec Pharmalab Limited IPO opens on [-] and closes on [-].

What is the lot size of Symbiotec Pharmalab Limited?

Answer Field

Symbiotec Pharmalab Limited lot size is [-] shares, and the minimum amount required is ₹[-].

How to apply for Symbiotec Pharmalab Limited IPO?

Answer Field

You can apply in Symbiotec Pharmalab Limited IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Symbiotec Pharmalab Limited IPO allotment?

Answer Field

The finalization of Basis of Allotment for Symbiotec Pharmalab Limited IPO will be done on [-], and the allotted shares will be credited to your demat account by [-].

When is Symbiotec Pharmalab Limited IPO listing date?

Answer Field

The Symbiotec Pharmalab Limited listing date is [-].

Who is the registrar of Symbiotec Pharmalab Limited IPO?

Answer Field

The registrar of Symbiotec Pharmalab Limited IPO is MUFG Intime India Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

JM Financial Limited,Avendus Capital Private Limited,Motilal Oswal Investment Advisors Limited,Nomura Financial Advisory & Securities (I) Pvt Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Symbiotec Pharmalab Limited IPO?

Answer Field

The fresh issue size is ₹[-] Crores equity shares.

What minimum lot size can retail subscribers subscribe to Symbiotec Pharmalab Limited?

Answer Field

Retail investors can subscribe to a minimum of one lot, [-] shares and ₹[-] amount.

How can I approve the UPI mandate request for Symbiotec Pharmalab Limited IPO?

Answer Field

To apply for Symbiotec Pharmalab Limited IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Symbiotec Pharmalab Limited?

Answer Field

The price of each Symbiotec Pharmalab Limited share will be ranging in between ₹[-] to ₹[-] per share.

What is the cut-off time for the UPI mandate for Symbiotec Pharmalab Limited IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, [-].

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|